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S U M M A R Y
In recent decades, the impact of dengue has increased both geographically and in intensity, and this
disease is now a threat to approximately half of the world’s population. An unexpected large outbreak of
dengue fever was reported in Xishuangbanna Dai Autonomous Prefecture, Yunnan Province, China, in
2013. This was the ﬁrst autochthonous outbreak with a signiﬁcant proportion of severe dengue cases in
mainland China in a decade. According to the 2009 World Health Organization guidelines, half of the 136
laboratory conﬁrmed cases during the epidemic were severe dengue. The clinical presentation included
severe haemorrhage (such as massive vaginal and gastrointestinal bleeding), severe plasma leakage
(such as pleural effusion, ascites, or hypoproteinaemia), and organ involvement (such as myocarditis and
lung impairment); 21 cases eventually deteriorated to shock. During this outbreak, all severe cases
occurred in adults, among whom about 43% had co-morbid conditions. Nucleic acid detection and virus
isolation conﬁrmed dengue virus serotype 3 (DENV-3) to be the pathogenic agent of this outbreak.
Phylogenetic analyses of envelope gene sequences showed that these DENV-3 isolates belonged to
genotype II. This ﬁnding is of great importance to understand the circulation of DENV and predict the risk
of severe disease in mainland China. Here, we provide a brief report of the epidemiology, clinical
manifestations, and aetiology of this dengue fever outbreak, and characterize DENV strains isolated from
clinical specimens.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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In mainland China, dengue is listed as a notiﬁable infectious
disease by the Ministry of Health of China, and sporadic dengue
epidemics have been reported in several provinces of Southeast
China, including Guangdong, Fujian, and Zhejiang. An autochtho-
nous dengue outbreak has not been recorded in Yunnan Province
in the last decade. From August to October 2013, an unexpected
large outbreak of dengue with a signiﬁcant proportion of severe
case was reported in Xishuangbanna Dai Autonomous Prefecture,
Yunnan Province, China. In this study, we investigated the
aetiology of this severe dengue outbreak and analyzed the dengue
virus (DENV) genotype isolated from clinical specimens.* Corresponding author. Tel.: +86 10 66948604; fax: +86 10 63898239.
E-mail address: qincf@bmi.ac.cn (C.-F. Qin).
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).2. Methods
Clinical information and samples were collected from patients
at Xishuangbanna Dai Autonomous Prefecture People’s Hospital
(XDAPPH). Serum samples obtained from suspected cases were
originally tested for the NS1 antigen and DENV serotype-speciﬁc
genome fragments were detected by in-house real-time RT-PCR
assays. A random subset of positive samples was sent to Beijing
Institute of Microbiology and Epidemiology for virus isolation and
full genome sequencing.1,2 The study was approved by the Ethics
Review Committee of Guangzhou 8th People’s Hospital (GPH).
3. Results
During the epidemic, a total of 1245 cases were identiﬁed in
Jinhong City, Mengla and Menghai counties of Xishuangbanna, of
which 19 were classiﬁed as imported cases returned from
Myanmar, Laos, and Thailand. Xishuangbanna is located at theciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. (A) Map showing the location of Xishuangbanna Dai Autonomous Prefecture and neighbouring areas. The numbers of dengue cases in each city/county of
Xishuangbanna are indicated. (B) Phylogenetic analyses of DENV-3 isolates were performed based on the complete envelope gene using the neighbour-joining method by
Tajima-Nei model in MEGA version 5.05. YN01 and YN02 isolated in this study are marked with red triangles; other isolates from DHF/DSS cases are marked with black
squares. All Chinese isolates are shown in red. DENV-1 strain WestPac, DENV-2 strain NGC, and DENV-4 strain H241 were used as outgroups.
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neighbours Myanmar, Laos, Bangladesh, Vietnam, and Thailand
(Figure 1A), where dengue is endemic. In this outbreak, 861
patients ranged in age from 15 to 45 years, 375 patients were aged
over 45 years and only nine patients were aged <15 years. Using
real-time RT-PCR assays, the cause of the epidemic was identiﬁed
to be DENV serotype 3 (DENV-3).
Among the 136 hospitalized cases, 70 were diagnosed as severe
dengue according to the 2009 World Health Organization (WHO)
guidelines,3 and their mean age was 44.17 years. Severe haemor-
rhage was seen in 28 patients, severe plasma leakage in 27 patients,
and 35 patients developed organ impairment. A total of 21 cases
ﬁnally deteriorated to shock; their mean age was 29.6 years. In
addition, 30 severe cases had underlying diseases such as fatty liver,
emphysema, and coronary heart disease. All patients received case
management by the collaborative team of doctors from XDAPPH and
GPH in accordance with the 2009 WHO guidelines. All patients
eventually recovered and were discharged from hospital.
Two DENV-3 strains from 17 patient acute-phase serum
samples were isolated in mosquito C6/36 cells and named YN01
and YN02, respectively. The complete genome sequences of the
two isolates were determined as described previously1,2 and were
submitted to GenBank (KF824902 and KF824903). Phylogenetic
analyses based on the complete envelop gene of these new isolates
were carried out by neighbour-joining method. The results showed
that YN01 and YN02 fell into genotype II together with mostSoutheast Asian strains isolated in recent years (Figure 1B). YN01
and YN02 have the highest amino acid homology (98.8%) to the
Bangladesh strain BDH02-7 isolated in 2002, suggesting that the
Yunnan isolates may have originated from neighbouring countries.
4. Discussion
This is the ﬁrst large severe dengue outbreak in Yunnan
Province during recent decades.4 In this epidemic, all the severe
cases were adults, which is quite different to the situation in other
Asian dengue hyperendemic countries, in which most severe cases
have been children. This explosive epidemic of severe dengue was
probably associated with immune status and the introduction of a
novel virus. This situation is similar to that of Taiwan in 19985 and
in Brazil in 2003,6 when DENV-3 was newly introduced. DENV-3
genotype II strains are now active and have been isolated from
dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS)
cases in Southeast Asia7 (Figure 1B). Virological characterization
and an analysis of viraemia in patients are currently underway to
clarify the potential association of virus virulence and disease
severity. Among the ﬁve DENV-3 genotypes, genotypes III and V
were recently isolated from patients in mild dengue fever
epidemics in China.1,8,9 Thus, at least three genotypes of DENV-
3 have been introduced into mainland China in recent years.
The invasion and spread of Aedes aegypti is also believed to have
played a critical role in the explosive nature of this outbreak.
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which is a less efﬁcient vector of DENV than A. aegypti. Generally,
dengue epidemics caused by A. albopictus tend to be mild and
short-lived,10 and this probably explains the dengue-free status of
Yunnan Province. However, during this outbreak, A. aegypti was
detected for the ﬁrst time in Xishuangbanna. The spread of A.
aegypti in this area has aroused special attention. The coinstanta-
neous introduction of a new DENV strain and an effective vector
into Xishuangbanna, a dengue-free region, carries a high risk for a
severe epidemic and endemicity. Strict vector control measures,
extensive ﬁeld surveillance, and laboratory investigations are
needed in the near future.
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